Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

China · Delayed Price · Currency is CNY

83.37

+5.56 (7.15%)

Oct 28, 2026, 3:00 PM CST

Market Cap	17.78B -1.5%
Revenue (ttm)	3.21B +27.3%
Net Income	259.25M -8.4%
EPS	1.22 -10.0%
Shares Out	213.23M
PE Ratio	68.34
Forward PE	51.04
Dividend	0.24 (0.29%)
Ex-Dividend Date	Sep 21, 2026

Volume	4,675,274
Open	79.23
Previous Close	77.81
Day's Range	79.00 - 85.77
52-Week Range	59.68 - 111.30
Beta	0.66
Analysts	Strong Buy
Price Target	106.00 (+27.14%)
Earnings Date	Oct 30, 2026

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2006

Employees 4,540

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688131

Full Company Profile

Financial Performance

In 2025, SHA:688131's revenue was 2.88 billion, an increase of 26.73% compared to the previous year's 2.27 billion. Earnings were 239.81 million, an increase of 18.96%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 688131 stock is "Strong Buy." The 12-month stock price target is ¥106.00, which is an increase of 27.14% from the latest price.

Price Target

¥106.00

(27.14% upside)

Analyst Consensus: Strong Buy

Stock Forecasts